Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Betterlife Pharma Inc (BETR.CN)

Betterlife Pharma Inc (BETR.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 13,116
  • Shares Outstanding, K 18,217
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.56
Trade BETR.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.90
  • Most Recent Earnings -0.09 on 07/31/20
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

    TSX Bottom 100 Stocks

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.680 +1.47%
on 10/28/20
1.100 -37.27%
on 10/09/20
-0.350 (-33.65%)
since 09/29/20
3-Month
0.430 +60.47%
on 09/16/20
2.580 -73.26%
on 07/30/20
-1.610 (-70.00%)
since 07/29/20
52-Week
0.400 +72.50%
on 03/24/20
3.000 -77.00%
on 05/11/20
-0.710 (-50.71%)
since 10/29/19

Most Recent Stories

More News
BetterLife Pharma Announces Consolidation of its Common Shares

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT) announces that it has consolidated its common shares on the basis of one new common share...

PVOTF : 0.1266 (-4.74%)
BETR.CN : 0.690 (-4.17%)
BETRF : 0.5433 (+0.61%)
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT) is pleased to announce that it has entered into an exclusivity agreement with Altum Pharmaceuticals...

BETR.CN : 0.690 (-4.17%)
BETRF : 0.5433 (+0.61%)
BetterLife Pharma Announces OTC Trading Symbol Change to "BETRF" Effective June 9, 2020

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: BETRF) (FRA: NPAT) is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA")...

BETR.CN : 0.690 (-4.17%)
BETRF : 0.5433 (+0.61%)
BetterLife Pharma Updates Shareholders on its Proposed Acquisition of Altum

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR) (OTCQB: PVOTF) (FSE: NPAT) is pleased to provide an update to its press release of whereby BetterLife announced...

BETR.CN : 0.690 (-4.17%)
PVOTF : 0.1266 (-4.74%)
BetterLife Pharma Confirms Re-Pricing of Warrants

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) confirms the re-pricing of warrants issued pursuant to financings completed in 2019 as announced...

BETR.CN : 0.690 (-4.17%)
BetterLife Pharma Highlights Results from Recent Clinical Reports and Studies on use of Interferon and Announces Appointment of Dr. Mark Swaim and Engagement of IR Group

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has appointed Dr. to the board of directors of its wholly-owned...

BETR.CN : 0.690 (-4.17%)
BetterLife Pharma Enters into a Licensing Agreement

, /PRNewswire/ - BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: PVOTF / FRA: NPAT) today announced that it has entered into an agreement to acquire worldwide rights (other...

BETR.CN : 0.690 (-4.17%)
CSE New Listing - Better Life Pharma Inc. Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Vancouver, British Columbia--(Newsfile Corp. - December 16, 2019) - Better Life Pharma Inc. (CSE: BETR) is one of the latest new listings on the Canadian Securities Exchange, having previously traded...

BETR.CN : 0.690 (-4.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

2nd Resistance Point 0.787
1st Resistance Point 0.753
Last Price 0.690
1st Support Level 0.683
2nd Support Level 0.647

See More

52-Week High 3.000
Fibonacci 61.8% 2.007
Fibonacci 50% 1.700
Fibonacci 38.2% 1.393
Last Price 0.690
52-Week Low 0.400

See More

Business Summary

BetterLife Pharma Inc is a wellness company engaged in offering self-care products to its customers. It has developed pharmaceutical grade products including CBD, phytocannabinoid and micronutrient derived formulations utilizing proprietary drug delivery technologies. The company's technology includes...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar